Early postmarketing surveillance of betaxolol hydrochloride, September 1985-September 1986.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D015784:Betaxolol; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D009798:Ocular Hypertension / Q000188:drug therapy; D011358:Product Surveillance, Postmarketing; D011412:Propanolamines / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D015784:Betaxolol